Terms: = Colorectal cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
80 results:
1. Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.
Chen S; Gu J; Wu K; Zhao X; Lu Y
Cancer Biol Med; 2024 Jun; 21(6):473-83. PubMed ID: 38940668
[TBL] [Abstract] [Full Text] [Related]
2. Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse.
Sallinger K; Gruber M; Müller CT; Bonstingl L; Pritz E; Pankratz K; Gerger A; Smolle MA; Aigelsreiter A; Surova O; Svedlund J; Nilsson M; Kroneis T; El-Heliebi A
J Transl Med; 2023 Aug; 21(1):528. PubMed ID: 37543577
[TBL] [Abstract] [Full Text] [Related]
3. PTPN9 dephosphorylates fgfr2 pY656/657 through interaction with ACAP1 and ameliorates pemigatinib effect in cholangiocarcinoma.
Zhao L; Liu J; Li K; Zhang C; Chen T; Liu Z; Tang Y; Hu X; Shi A; Shu L; Huang S; Lian S; Zhang M; Li H; Sun J; Yu X; Zhang Z; Zhang Z; Xu Y
Hepatology; 2024 Apr; 79(4):798-812. PubMed ID: 37505213
[TBL] [Abstract] [Full Text] [Related]
4. Detection of Nine Oncogenes Amplification in Lung and colorectal cancer Formalin-Fixed Paraffin-Embedded Tissue Samples using Combined Next-Generation Sequencing-Based Script and Digital Droplet Polymerase Chain Reaction.
Bontoux C; Guyard A; Lupo A; Diallo K; Rebah K; Hercent A; Guenzi E; Cros J; Lamoril J; Leroy K; Theou-Anton N
Cancer Control; 2023; 30():10732748231167257. PubMed ID: 37386758
[TBL] [Abstract] [Full Text] [Related]
5. The Emerging Role of Circulating Tumor DNA in Non-colorectal Gastrointestinal cancers.
Lee MS; Kaseb AO; Pant S
Clin Cancer Res; 2023 Sep; 29(17):3267-3274. PubMed ID: 37092904
[TBL] [Abstract] [Full Text] [Related]
6. Decoding the Conformational Selective Mechanism of FGFR Isoforms: A Comparative Molecular Dynamics Simulation.
Zhang M; Yasen M; Lu S; Ma DN; Chai Z
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985681
[TBL] [Abstract] [Full Text] [Related]
7. Molecular Landscape and Association With Crohn Disease of Poorly Cohesive Carcinomas of the Nonampullary Small Bowel.
Tedaldi G; Guerini C; Angeli D; Furlan D; Libera L; Lenti MV; Grillo F; Fassan M; Solcia E; Sessa F; Paulli M; Di Sabatino A; Ulivi P; Vanoli A
Am J Clin Pathol; 2023 Apr; 159(4):315-324. PubMed ID: 36812376
[TBL] [Abstract] [Full Text] [Related]
8. Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.
Hua H; He W; Chen N; He Y; Wu G; Ye F; Zhou X; Li Y; Ding Y; Zhong W; Teng L; Jiang W; Sheng Q
Front Immunol; 2022; 13():974793. PubMed ID: 36700211
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population.
Lai X; Yu R; Ou Q; Bao H; Wu X; Shao Y; Li Y; Zhang Y; Ding Q
Cancer Med; 2023 Mar; 12(5):6009-6015. PubMed ID: 36325957
[TBL] [Abstract] [Full Text] [Related]
10. Prospective analysis of the expression status of fgfr2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study.
Yasui H; Takeno A; Hara H; Imamura H; Akamatsu H; Fujitani K; Nakane M; Kondoh CN; Yukisawa S; Nasu J; Miyata Y; Makiyama A; Ishida H; Yoshida N; Matsumura E; Ishigami M; Sugihara M; Ochiai A; Doi T
Int J Colorectal Dis; 2022 Jun; 37(6):1393-1402. PubMed ID: 35585358
[TBL] [Abstract] [Full Text] [Related]
11. Negative Ultraselection of Patients With
Randon G; Maddalena G; Germani MM; Pircher CC; Manca P; Bergamo F; Giordano M; Sposetti C; Montagna A; Vetere G; Zambelli L; Rasola C; Boccaccino A; Pagani F; Ambrosini M; Massafra M; Fontanini G; Milione M; Fassan M; Cremolini C; Lonardi S; Pietrantonio F
JCO Precis Oncol; 2022 Apr; 6():e2200037. PubMed ID: 35544729
[TBL] [Abstract] [Full Text] [Related]
12. TNFRSF11B Suppresses Memory CD4+ T Cell Infiltration in the Colon cancer Microenvironment: A Multiomics Integrative Analysis.
Zhang JR; Hou P; Wang XJ; Weng ZQ; Shang-Guan XC; Wang H; You F; Lin BQ; Huang ZY; Chen XQ
Front Immunol; 2021; 12():742358. PubMed ID: 34938284
[TBL] [Abstract] [Full Text] [Related]
13. Physical activity advice in the UK bowel cancer screening setting: qualitative healthcare professional perspectives.
Semper K; Hernon J; Wynter T; Baker K; Saxton JM
Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34151969
[TBL] [Abstract] [Full Text] [Related]
14. A comparative study of RTK gene status between primary tumors, lymph-node metastases, and Krukenberg tumors.
Wang B; Tang Q; Xu L; Teng X; Ding W; Ren G; Wang X
Mod Pathol; 2021 Jan; 34(1):42-50. PubMed ID: 32732929
[TBL] [Abstract] [Full Text] [Related]
15. A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases.
Jian M; Ren L; He G; Lin Q; Tang W; Chen Y; Chen J; Liu T; Ji M; Wei Y; Chang W; Xu J
J Transl Med; 2020 Jun; 18(1):234. PubMed ID: 32532289
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic evaluation of a deep learning model for optical diagnosis of colorectal cancer.
Zhou D; Tian F; Tian X; Sun L; Huang X; Zhao F; Zhou N; Chen Z; Zhang Q; Yang M; Yang Y; Guo X; Li Z; Liu J; Wang J; Wang J; Wang B; Zhang G; Sun B; Zhang W; Kong D; Chen K; Li X
Nat Commun; 2020 Jun; 11(1):2961. PubMed ID: 32528084
[TBL] [Abstract] [Full Text] [Related]
17. Overcoming Resistance to Targeted Therapies in Gastrointestinal cancers: Progress to Date and Progress to Come.
Chen C; Di Bartolomeo M; Corallo S; Strickler JH; Goyal L
Am Soc Clin Oncol Educ Book; 2020 May; 40():161-173. PubMed ID: 32421451
[TBL] [Abstract] [Full Text] [Related]
18. Dynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab.
Zhang H; Yuan L; Liu L; Yan C; Cheng J; Fu Q; Tong Z; Jiang W; Zheng Y; Zhao P; Zhang G; Fang W
BMC Cancer; 2020 May; 20(1):416. PubMed ID: 32404198
[TBL] [Abstract] [Full Text] [Related]
19. Family history of colorectal cancer and prevalence of advanced colorectal neoplasia in asymptomatic screened populations in different age groups.
Sekiguchi M; Kakugawa Y; Nakamura K; Matsumoto M; Tomizawa Y; Murakami Y; Saito Y; Matsuda T
Gastrointest Endosc; 2020 Jun; 91(6):1361-1370. PubMed ID: 32004550
[TBL] [Abstract] [Full Text] [Related]
20. First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced cancer.
Kim SB; Meric-Bernstam F; Kalyan A; Babich A; Liu R; Tanigawa T; Sommer A; Osada M; Reetz F; Laurent D; Wittemer-Rump S; Berlin J
Target Oncol; 2019 Oct; 14(5):591-601. PubMed ID: 31502117
[TBL] [Abstract] [Full Text] [Related]
[Next]
